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Abstract
Protein misfolding is linked to a wide array of human disorders, including Alzheimer’s disease, Parkinson’s
disease and type II diabetes1,2. Protective cellular protein quality control (PQC) mechanisms have evolved to
selectively recognize misfolded proteins and limit their toxic effects3,4,5,6,7,8,9, thus contributing to the
maintenance of the proteome (proteostasis). Here we examine how molecular chaperones and the ubiquitin–
proteasome system cooperate to recognize and promote the clearance of soluble misfolded proteins. Using a
panel of PQC substrates with distinct characteristics and localizations, we define distinct chaperone and
ubiquitination circuitries that execute quality control in the cytoplasm and nucleus. In the cytoplasm,
proteasomal degradation of misfolded proteins requires tagging with mixed lysine 48 (K48)- and lysine 11 (K11)linked ubiquitin chains. A distinct combination of E3 ubiquitin ligases and specific chaperones is required to
achieve each type of linkage-specific ubiquitination. In the nucleus, however, proteasomal degradation of
misfolded proteins requires only K48-linked ubiquitin chains, and is thus independent of K11-specific ligases and
chaperones. The distinct ubiquitin codes for nuclear and cytoplasmic PQC appear to be linked to the function of
the ubiquilin protein Dsk2, which is specifically required to clear nuclear misfolded proteins. Our work defines
the principles of cytoplasmic and nuclear PQC as distinct, involving combinatorial recognition by defined sets of
cooperating chaperones and E3 ligases. A better understanding of how these organelle-specific PQC
requirements implement proteome integrity has implications for our understanding of diseases linked to
impaired protein clearance and proteostasis dysfunction.

Main
Misfolded proteins, arising during biogenesis or through proteotoxic damage, are highly toxic; they accumulate
in distinct regions (puncta) within cells6,7,8,9 and form aggregates that are associated with neurodegenerative
diseases1. Misfolded proteins must be cleared: the process involves the cooperation of chaperones and
components of the ubiquitin–proteasome system (UPS)3,4,5 (Fig. 1a), but is poorly understood.
Fig. 1: Combined deletion of certain E3 ligases impairs the clearance of misfolded proteins.

a, Proteins can become misfolded for different reasons; in our experiments (involving non-native proteins), the
temperature-sensitive proteins Ubc9ts or luciferasets misfold at temperatures of 37 °C; VHL misfolds in the
absence of elongin BC (BC); and CPY‡ misfolds because it lacks its signal sequence (SS). Conserved pathways
dispose of these aberrant proteins, with initial recognition by chaperones of the Hsp70 and Hsp90 families, Jdomain proteins and Sse1; ubiquitination by one or more E3 ligases; and targeting for proteasomal degradation.
Blocking any step (for instance, with the proteasome inhibitor bortezomib (Bz) or by omitting E3s or chaperones)
triggers the sequestration of misfolded proteins into puncta. b, c, VHL and CPY‡ form puncta upon proteasome
inhibition. Wild-type cells expressing galactose-inducible GFP–VHL or CPY‡–GFP were shifted to glucose media
with 50 μM Bz or vehicle control (Ctrl) for 1 h to shut off expression. Fixed cells were imaged by fluorescence
microscopy. c, Percentage of cells with GFP–VHL puncta. d, Deleting individual E3s implicated in PQC does not
increase puncta formation. Experiment performed as in panel b, but using strains with endogenous deletions of
E3s. WT, wild type. e, f, Misfolded proteins are stabilized in ∆ubr1∆san1 and ∆doa10∆hrd1 strains: e,

cycloheximide (CHX) chase and immunoblot were used to assess the stability of GFP–VHL in E3 double-deletion
strains, or following 50 μM Bz treatment; f, densitometric quantification of bands relative to t = 0 (mean ± s.e.m.
from three biologically independent experiments). g, Multiple misfolded proteins are sequestered in the same
subcellular location. Experiment performed as in panel b, but in strains co-expressing VHL with CPY‡. Images
represent more than 100 cells from each of three biologically independent experiments. Scale bars represent
2 μm. h, Deleting certain E3 pairs increases puncta formation. Experiment performed as in panel b, but using
strains with endogenous deletions of E3 pairs. On the right, cells were shifted to 37 °C for the shut-off. i,
Clearance of misfolded proteins requires a soluble E3, Ubr1 or San1, and a membrane-bound E3, Doa10 or
Hrd1. c, d, h, 300 cells were counted per condition. Bars represent mean ± s.e.m. from three biologically
independent experiments, except for the wild type in panel d (seven biologically independent experiments).
Statistically significant differences versus wild type, calculated by two-tailed Student’s t-test (c), or one-way
analysis of variance (ANOVA) plus Dunnett’s multiple comparisons test (d, h), are indicated with the
adjusted P value, or with **** for P < 0.0001.
To better understand the PQC of soluble proteins, we used a panel of substrates that reflects different types of
misfolding, including two temperature-sensitive proteins (Ubc9ts and luciferasets), a protein (the Von Hippel–
Lindau tumour suppressor, VHL) that cannot fold without its oligomeric partners elongin B and C, and
translocation-defective carboxypeptidase yscY (CPY*) that lacks its signal sequence (CPY‡)6,7,9,10. We found that
terminally misfolded VHL or CPY‡ conjugated to green fluorescent protein (GFP) was cleared within 1 hour, with
only around 10% of cells containing GFP-positive puncta (Fig. 1b, c). Blocking proteasomal degradation with the
proteasome inhibitor bortezomib led to the accumulation of these proteins in GFP-positive puncta.
Temperature-sensitive proteins, such as Ubc9ts–GFP, are diffuse when folded at 30 °C, but upon misfolding at
37 °C are also degraded through the proteasome or accumulate in puncta (Extended Data Fig. 1a)6,7. Of note,
native wild-type Ubc9 is soluble at either temperature.
To identify the E3 ubiquitin (Ub) ligases involved in PQC, we expressed GFP–VHL in a library of 41 Saccharomyces
cerevisiae single-deletion strains comprising most non-essential E3 ubiquitin ligases (Extended Data Fig. 1b),
including E3s that have previously been implicated in PQC (Fig. 1d). No single deletion caused a notable increase
in puncta formation compared with wild-type cells, suggesting that no single E3 is essential for PQC of this
substrate.
Given that E3 ligases can have redundant functions11, we next deleted pairs of E3s previously implicated in PQC.
The cytoplasmic E3 Ubr1 and the nuclear E3 San1 cooperate in the clearance of some cytoplasmic proteins11,12.
The E3s Hrd1, which is anchored in the endoplasmic reticulum (ER) membrane, and Doa10, also localized to the
ER and to the inner nuclear membrane13, trigger ER-associated protein degradation (ERAD)14. We found that
both ∆ubr1∆san1 and ∆doa10∆hrd1 strains abrogated the degradation of all PQC substrates to the same extent
as proteasome inhibition (see, for example, the results of cycloheximide chase in Fig. 1e, f and Extended Data
Fig. 1c). Notably, all PQC substrates accumulated in the same puncta in these strains (Fig. 1g and Extended Data
Fig. 1d). Therefore, multiple misfolded proteins use the same E3 systems for proteasomal degradation, and are
sequestered together in the same PQC compartments in the absence of these E3 systems.
To determine why the deletion of either E3 pair stabilized our PQC substrates similarly, we tested the effect of
doubly deleting all possible combinations of these four E3 ligases—Ubr1, San1, Doa10 and Hrd1 (Fig. 1h and
Extended Data Fig. 1e). Puncta formation and cycloheximide chase assays showed that only specific
combinations of deletions abrogate clearance. Strong stabilization was observed
in ∆ubr1∆san1 and ∆doa10∆hrd1 strains. A moderate effect was found with ∆doa10∆ubr1 and ∆hrd1∆san1.
Strikingly, ∆doa10∆san1 and ∆hrd1∆ubr1 had no effect on PQC, suggesting that these pairs of ligases—
Doa10/San1 and Hrd1/Ubr1—provide parallel, optimal combinations for PQC clearance. This E3 circuit logic
appeared to be general, as it operated for all substrates tested at 30 °C and 37 °C. Thus PQC clearance requires

parallel pathways of specific pairs of E3 ligases, combining one of the soluble E3s (either Ubr1 or San1; blue in
Fig. 1i) and one of the membrane-bound E3s (either Doa10 or Hrd1; red). Overexpressing an E3 in any of the
double-deletion strains rescued clearance only in those strains deleted for that particular E3 (Extended Data
Fig. 1f). Therefore, E3 function is not interchangeable, even at higher expression levels, and PQC requires
specific E3 combinations. The functional cooperation between E3 ligases may involve a physical complex, as
immunoprecipitation experiments show that San1 associates with Doa10 but not with Hrd1 (Extended Data
Fig. 2). We were unable to co-immunoprecipitate Ubr1 with Hrd1 (or Doa10), so these ligases may bind
transiently, or cooperate functionally through separate complexes.
To examine whether the PQC defects observed above were linked to impaired ubiquitination, we expressed a
terminally misfolded Flag-tagged VHL mutant (L158P; ref. 10) in either wild-type cells or the panel of double E3
deletions. VHL was immunoprecipitated under harsh denaturing conditions, followed by anti-ubiquitin
immunoblot detection (Fig. 2a). In wild-type cells, polyubiquitin chains were clearly attached to VHL. In
the ∆ubr1∆san1 and ∆doa10∆hrd1 cells, VHL ubiquitination was markedly reduced, indicating that these E3 pairs
promote VHL clearance through ubiquitination. No clear differences in VHL ubiquitination were observed in any
other strains. A similar strategy examined how E3 deletions specifically affect VHL tagging with a canonical
proteasomal signal, K48-linked Ub (in which the lysine 48 residue of one ubiquitin molecule is joined to the
carboxyl terminus of the next ubiquitin in the chain, and so on) (Fig. 2b)5. Surprisingly, K48-linked VHL
ubiquitination was strongly reduced in ∆ubr1∆san1 but not in ∆doa10∆hrd1 cells. Conversely, the alternative
proteasome-targeting signal, K11-linked Ub5,15,16,17,18, was unaffected in ∆ubr1∆san1 cells but was abrogated
in ∆doa10∆hrd1 cells. Note that misfolded VHL was ubiquitinated with both K48-linked and K11-linked ubiquitin
chains in wild-type cells. A quantitative ubiquitin-linkage-specific ELISA assay for K11- or K48-linked chains
confirmed that Ubr1 and San1 mediate VHL tagging with K48–Ub chains, whereas Doa10 and Hrd1 promote K11linked ubiquitination (Extended Data Fig. 3a, b). Upon proteasome inhibition, the VHL puncta co-localized with
both K11- and K48-linked ubiquitin (Fig. 2c), supporting the conclusion that VHL itself is modified with ubiquitin
chains containing both K48 and K11 linkages.

Fig. 2: Cytoplasmic misfolded proteins are modified with both K11- and K48- linked ubiquitin chains.

a, VHL ubiquitination is impaired in ∆ubr1∆san1 and ∆doa10∆hrd1 strains. Denaturing immunoprecipitation (IP)
for Flag–VHL was followed by immunoblot for ubiquitin in WT or E3 double-deletion strains. Deletion of the cotranslational E3s Ltn1 and Hel2 served as a control. b, K48–Ub and K11–Ub linkages are reduced on Flag–VHL
in ∆ubr1∆san1 and ∆doa10∆hrd1 strains, respectively. Experiment performed as in panel a, but using K48–Ub or
K11–Ub specific antibodies for immunoblot. c, K48–Ub and K11–Ub co-localize with GFP–VHL puncta.
Experiment performed as in Fig. 1b. Fixed cells were spheroplasted and immunostained before imaging by
confocal fluorescence microscopy. Images represent more than 100 cells from each of three independent
experiments. Scale bars represent 2 μm. d–f, VHL clearance is impaired in the absence of K11–Ub linkages. d,
Cells co-expressing galactose-inducible GFP–VHL, with either WT or K-to-R mutant Ub as their only ubiquitin
source, were shifted to glucose media for 1 h to shut off expression. 300 cells were counted per condition. e,
Percentage of cells with GFP–VHL puncta (mean ± s.e.m. from three biologically independent experiments). Only
UbK11R significantly altered the percentage of puncta-positive cells versus WT (one-way ANOVA plus Dunnett’s
multiple comparisons test; ****P < 0.0001). f, CHX chase and immunoblot to assess GFP–VHL stability in Ub
mutant strains. Graphs represent densitometric quantification relative to t = 0 (mean ± s.e.m. from three
biologically independent experiments). g, Doa10/Hrd1 and Ubr1/San1 E3 ligases collaborate to ubiquitinate
misfolded proteins with branched K11/K48 chains, thereby targeting them for proteasomal clearance. Inhibition

of either type of linkage results in the sequestration of the misfolded proteins with only UbK48 or UbK11 into
puncta. a, b, f, Immunoblots represent three biologically independent experiments.
We next examined PQC in cells expressing a single copy of ubiquitin that carries individual lysine to arginine (Kto-R) mutations, and is therefore unable to form specific linkages (Fig. 2d). UbK48R is lethal19, and could not be
tested. VHL was degraded in all other K-to-R variants except in UbK11R cells, where VHL clearance was impaired,
leading to its accumulation in puncta (Fig. 2e, f). Importantly, K11–Ub linkages were not generally required for
proteasomal clearance, given that the non-misfolded cytoplasmic substrates Ub-R-GFP and UbG76V–GFP were
degraded normally in UbK11R cells (Extended Data Fig. 4). Consistent with our data implicating ER-resident E3
ligases in K11–Ub tagging of soluble PQC substrates, the UbK11R strain has been shown to be sensitive to ER
stress16.
We next examined whether misfolded VHL is tagged with mixed K48- and K11-linked ubiquitin chains. Sequential
double immunoprecipitations first isolated Flag-tagged VHL and then isolated either K48- or K11-linked chains
(Extended Data Fig. 5a). The presence of K11- or K48-linked chains in either flow-through or bound fractions was
then detected by immunoblot. All of the K11- and K48-linked chains were present only in the bound fractions of
each immunoprecipitate (Extended Data Fig. 5b), showing that misfolded VHL is tagged with both K11- and K48linked ubiquitin chains. Additionally, an antibody that recognizes branched K11/K48 linkages, with K11- and K48linked chains extending from the same ubiquitin molecule18, reacted with misfolded VHL in both
immunofluorescence and immunoprecipitation experiments (Extended Data Fig. 5c–e). Notably, reactivity with
the branched K11/K48 antibody required the presence of both K48- and K11-specific E3 ligases (Extended Data
Fig. 5e). We conclude that a dual ubiquitin code involving both K11 and K48 is required for clearance of soluble
PQC substrates. K11 ubiquitination is mediated by either of the membrane-bound E3s, Doa10 or Hrd1, and K48
ubiquitination is mediated by either of the soluble E3s, Ubr1 or San1, thus explaining the requirement for pairs
of E3 ligases for PQC clearance. Given that deletion of one E3 pair did not abrogate the action of the other,
addition of K11- or K48-linked chains does not require a particular sequential order.
It is unclear how chaperone proteins—known to be key mediators of PQC1,3,4—facilitate ubiquitination and
clearance. Chaperones could simply maintain the solubility of misfolded proteins, or they could specifically
direct them along an E3 clearance pathway (Fig. 3a). We used the ubiquitin-linkage-specific ELISA assay to
identify whether chaperones implicated in PQC are required to tag misfolded VHL with either K11–Ub or K48–Ub
(Fig. 3b). We found that cells lacking Ssa1 and Ssa2—the major cytosolic proteins of the heat-shock protein
(Hsp)70 family required for PQC clearance7,10,20—were strongly impaired in ubiquitination with either linkage. By
contrast, the ribosome-associated Hsp70s Ssb1 and Ssb2 were dispensable for degradation10 and ubiquitination.

Fig. 3: K11- and K48- linked ubiquitination of misfolded proteins involves different chaperones.

a, Molecular chaperones are involved in the ubiquitination of misfolded proteins by E3 ligases. b, Relative
amounts of UbK11 and UbK48 present on Flag–VHL in chaperone-deletion strains compared with WT. WT or
chaperone-deletion strains expressing Flag–VHL were lysed after 1 h Bz treatment. ELISA for Ub linkages was
then performed as described in Extended Data Fig. 3a. Bars represent normalized values from each strain
(mean ± s.e.m. from three biologically independent experiments) expressed as a proportion of normalized WT.
Strains with statistically significant differences versus WT by one-way ANOVA plus Dunnett’s multiple
comparisons test are indicated with the adjusted P value or with **** for P < 0.0001. c, Ubiquitination of
misfolded proteins through K11 and K48 linkages proceeds through the action of different chaperone pathways.
Binding of Hsp70s to substrates relies on many J-domain proteins, themselves often chaperones that ferry
substrates for Hsp70 binding3,4. We examined VHL ubiquitination in cells lacking two J-domain proteins, Ydj1 and
Sis1, that have been implicated in PQC7,8,9,11,20,21,22. Strikingly, each J-domain protein reduced ubiquitination, but
in a linkage-specific manner. We found that ∆ydj1 cells showed reduced K48 ubiquitination, albeit to a modest
degree, probably because Ydj1 is partially redundant with other J-domain co-factors7. Depleting cells of the
essential Sis1 left K48 ubiquitination unaffected but caused a dramatic loss of K11 ubiquitination. Of note, three
other chaperones important for PQC—the Hsp70 nucleotide-exchange factor Sse1 (an Hsp110 chaperone),
Hsp90, and Sti1/HOP (which bridges the interaction of Hsp70 with Hsp90)7,10,11,23—were all required for K48
ubiquitination but were dispensable for K11 ubiquitination. We conclude that specific chaperone pathways
direct PQC substrates to distinct E3 pathways to promote mixed linkage ubiquitination (Fig. 3c). Sis1 cooperates
with Hsp70 in promoting Doa10/Hrd1-mediated K11 ubiquitination, whereas the Ydj1/Sse1/Sti1 chaperones
cooperate with Hsp70 and Hsp90 for Ubr1/San1-mediated K48 ubiquitination. Requiring two distinct E3 ligases
to communicate with distinct chaperone pathways may provide a checkpoint in the triage decision to refold or
degrade.

That cytoplasmic misfolded proteins are degraded via a nuclear E3 ligase—San1—was puzzling. In principle,
misfolded cytoplasmic proteins might be actively imported into the nucleus for degradation11,12,20,23.
Alternatively, they might passively diffuse through the nuclear pores, owing to their small size24. To directly
investigate cytoplasmic-specific and nuclear-specific PQC degradation pathways, we spatially restricted two PQC
substrates—VHL and luciferasets—to the nucleus by using a nuclear localization signal (NLS), or to the cytoplasm
by using a nuclear export signal (NES; Fig. 4a). Similar results were obtained for both substrates, corroborating
the generality of our conclusions. Treatment with bortezomib showed that both nuclear and cytoplasmic
variants are degraded by the UPS (Fig. 4b, c and Extended Data Fig. 6a). NES–GFP–VHL accumulated in
cytoplasmic perinuclear puncta, whereas NLS–GFP–VHL accumulated in intranuclear puncta (Fig. 4b). Thus,
misfolded proteins are either degraded or form inclusions in the cellular compartment where misfolding occurs.

Fig. 4: Confining misfolded proteins to the nucleus or cytoplasm alters their PQC requirements.

a, b, Upon proteasome inhibition, NLS–GFP–VHL (NLS here) and NES–GFP–VHL (NES) accumulate in the nucleus
or cytoplasm, respectively. (The red crosses indicate that the proteins are not transported across the nuclear
envelope, because of the presence of the NLS or NES.) The locations of the E3s Ubr1, Hrd1, Doa10 and San1 are
also shown. b, Expression of NLS–GFP–VHL or NES–GFP–VHL in WT cells was shut off in glucose media with
50 μM Bz for 1 h. Cells were immunostained for Nsp1 (a nuclear pore protein; red) and imaged by fluorescence
microscopy. Images represent three biologically independent experiments. Scale bars represent 2 μm. c, NLS–
GFP–VHL and NES–GFP–VHL are cleared by the proteasome. Cycloheximide chase and immunoblot were used to
assess the stability of these proteins in WT cells treated with (Bz) or without (Ctrl) 50 μM Bz. Immunoblots
represent three biologically independent experiments. d, Confining VHL to the nucleus or cytoplasm alters its E3
requirement. The graph shows the percentage of cells with NLS–GFP–VHL or NES–GFP–VHL puncta in deletion
strains following 1 h of shut-off. e, Nuclear VHL has severely reduced K11–Ub ubiquitin linkages. ELISA
performed as in Fig. 2c, but using GFP-multiTrap instead of α-Flag-conjugated plates. f, Nuclear VHL clearance is

unaffected by K11–Ub linkages. Experiment performed as in panel d, but using cells expressing WT ubiquitin or
UbK11R as the only ubiquitin source. g, h, Clearance of NLS–GFP–VHL, but not NES–GFP–VHL, requires Dsk2. CHX
chase performed as in c, but in WT or ∆dsk2 cells. The densitometric quantification in panel h is shown relative
to t = 0 (mean ± s.e.m. from three biologically independent experiments). i, Nuclear and cytoplasmic misfolded
proteins have distinct clearance requirements. Cytoplasmic misfolded proteins require tagging with both K11–
Ub and K48–Ub by chaperones and E3 ligases for proteasomal degradation. In the nucleus, tagging with K48–Ub
is sufficient for recognition by Dsk2 and subsequent proteasomal degradation. d–f, Bars represent mean ± s.e.m.
from three biologically independent experiments. Statistically significant differences versus WT (d, f) or GFP–VHL
(e) by one-way ANOVA plus Dunnett’s multiple comparisons test (d, e), or two-tailed Student’s t-test (f), are
indicated (adjusted P value, or ****P < 0.0001; NS, P > 0.05).
Degradation of cytoplasmic NES–VHL or NES–luciferasets required the K11 ubiquitin ligases Doa10 and Hrd1, but
only the cytoplasmic K48 ligase Ubr1 (Fig. 4d and Extended Data Fig. 6b). Therefore, San1 is dispensable for UPS
degradation of strictly cytoplasmic PQC substrates. Surprisingly, the nuclear NLS–GFP–VHL or
luciferasets required only the nuclear K48 ligase, San1, for clearance.
Consistent with their E3 requirements, cytoplasm-restricted misfolded NES-labelled proteins were conjugated to
both K11- and K48-linked chains at levels similar to those of their unmodified counterparts. However, nuclearrestricted misfolded NLS-labelled proteins were ubiquitinated only with K48 chains, with the K11 signal reduced
to baseline levels (Fig. 4e and Extended Data Fig. 6c). Notably, nuclear misfolded proteins tagged with K48–Ub
were efficiently cleared by the proteasome (Fig. 4c, d and Extended Data Fig. 6a). Confirming the distinct role of
K11 ubiquitination in nuclear versus cytoplasmic PQC, clearance of NES-tagged misfolded proteins was impaired
in UbK11R cells, whereas degradation of nuclear-restricted PQC substrates was unaffected (Fig. 4f and Extended
Data. 6d).
To understand the differences between nuclear and cytoplasmic PQC, we first focused on the ubiquilin Dsk2—a
predominantly nuclear25 shuttling factor that physically ferries K48-ubiquitinated proteins to the proteasome26.
Strikingly, cells lacking Dsk2 were impaired in clearance of NLS-tagged but not NES-tagged GFP–VHL (Fig. 4g, h).
We propose that Dsk2 in the nucleus increases the affinity of K48-only nuclear misfolded proteins for the
proteasome.
We examined the role of chaperone circuits in nuclear versus cytoplasmic PQC through functional and
proteomic approaches. We found that depletion of Sis1—required for K11 ubiquitination (Fig. 3b)—had no
effect on the clearance of NLS-tagged proteins, but, as expected, blocked the clearance of NES-tagged variants
(Extended Data Fig. 6d). Interestingly, Hsp90, Sti1, Sse1 and Ydj1 were required only for K48 ubiquitination and
clearance of cytoplasmic substrates. Only the Hsp70 proteins—Ssa1 and Ssa2—were required for nuclear PQC.
Mass spectrometry based on stable-isotope labelling by amino acids in cell culture (SILAC) further indicated that
PQC of nuclear and cytoplasmic misfolded proteins involves different circuitries. Analysis of immunoprecipitates
of NLS-tagged or NES-tagged GFP–VHL (Extended Data Fig. 7 and Extended Table 1) revealed localizationdependent proteostasis interactors (with a log2(VHL/control ratio) of greater than 0.5). Both nuclear and
cytoplasmic PQC substrates shared enrichments in proteasomal subunits and several chaperones, including four
Hsp70 proteins. Consistent with their selective requirement for cytoplasmic PQC, Hsp82 and Sis1 specifically
associated with NES-tagged VHL. Of note, Cdc48/p97 also selectively associated with NES-tagged VHL, whereas
the TRiC/CCT chaperonin selectively associated with NLS-tagged VHL (Extended Data Fig. 7c). The importance of
these interactions for PQC will be explored in future studies.
We conclude that the clearance of nuclear and cytoplasmic PQC substrates requires distinct ubiquitin codes,
distinct E3 ligases, and distinct chaperone sets. Cytoplasmic PQC requires both K11- and K48-linked ubiquitin,

while nuclear PQC requires only K48-linked ubiquitin. Given that the misfolded protein is the same in both
compartments, these distinct requirements are unlikely to relate to the substrate’s structural properties, but
instead arise from differences in the proteostasis machineries that maintain the nuclear and cytoplasmic
proteomes.
Our study opens new perspectives for understanding the circuits and logic of misfolded-protein quality control
(Fig. 4i). We define a general PQC path through which specific, non-redundant networks of E3 ligases and
chaperones mediate post-translational PQC clearance. Surprisingly, we also uncover marked differences in the
pathways of cytoplasmic and nuclear PQC. It is possible that nuclear and cytoplasmic proteasomes differ in
composition27 or concentration28, affecting their ability to recognize ubiquitinated substrates effectively. It is
also possible that K11-linked ubiquitin chains facilitate recognition by another cytoplasmic PQC factor.
Intriguingly, Sis1, required for K11 linkages, can act as a sorting factor9, and is sequestered in protein
aggregates7,8,9,21,29. Nuclear ubiquilin Dsk2 shuttles K48-linked substrates to nuclear proteasomes, whereas in the
cytoplasm, mixed K11/K48 chains enhance the affinity of misfolded proteins for cytoplasmic proteasomes,
probably by engaging multiple ubiquitin receptors in the 19S proteasome cap30.
The distinct ubiquitin linkage requirements for nuclear and cytoplasmic PQC might respond to distinct regulatory
and functional rationales for the triage decision between (re-)folding and targeting for degradation. For
example, the importance of the UPS in chromatin regulation31 could sensitize the nuclear proteome to protein
misfolding and aggregation32—perhaps leading to relaxed ubiquitination requirements for proteasomal
recognition. By contrast, the cytosol is a site of active protein biogenesis, assembly and targeting, requiring
productive folding intermediates to be safeguarded. Requiring a dual ubiquitin code for cytoplasmic PQC—
mediated by distinct E3 ligases and chaperones—would provide a checkpoint to ensure that only nonproductive, misfolded proteins are degraded. Of interest, ubiquilin and the PQC E3 ligases identified here are
associated with a host of human diseases (Extended Table 2). Dissection of these circuits in normal and diseased
states might provide mechanistic clues and open up therapeutic opportunities.
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Additional information

Extended Data Table 2 Human homologues of the ubiquitination machinery characterized here are associated
with a range of diseases
Enriched proteins [log,(NLS-VH L/Control) > 0.5)
Fasta headers log2(Median NLS/Control)
URA3
2.077
CCT5
1.550

SSA2
SSA4
MKT1
TSA1
TRX2
CCT8
ARO1
MDN1
RPT6
CCT7
TUB1
CCT3
GCD6
TRX1
BGL2
VMA2
AAH1
NEW1
RPA135
SSA1
YNL134C
URA?
PRE10
EFT1;EFT2
URA2
RPT1
NUG1
HTS1
SSB2
SAM1
RPB2
KRE33
RPN2
FAS2
ADE6
MIS1
YEF3
CCT6
CPA2
CCT4
ADE3
RRP5
LEU1
CRM1
GCN1
HIS1
HIS4
YNL134C
DBP5

1.334
1.239
1.208
1.203
1.035
0.952
0.923
0.902
0.879
0.873
0.867
0.841
0.837
0.808
0.790
0.775
0.773
0.759
0.745
0.745
0.728
0.710
0.699
0.688
0.684
0.670
0.657
0.649
0.642
0.630
0.615
0.605
0.578
0.561
0.552
0.550
0.545
0.540
0.524
0.520
0.516
0.514
0.510
0.508
0.507
0.507
0.504
3.229
2.501

RKl1
URA3
SSA4
SHM1
SEC14
TSA1
SSA2
IMD3;IMD2
SSA1
TRX2
GDH1
BGL2
TPl1
RPN3
CCT5
CIT1
TIF4631
CPA2
RRP5
PRE5
IPP1
MET17
DYS1
SIS1
TRX1
MMF1
ENO2
PGl1
RPT6
PRE9
HOM6
HXK2
ERG10
BMH1
UBA1
PGK1
HTS1
YPT52
SSB2
URA2
RPN6
FPR4
TKL1
PRE6
RNR4
CDC48
SDH1
HSP82
TUB1

2.494
2.319
2.166
1.835
1.727
1.234
1.234
1.213
1.199
1.054
0.984
0.964
0.880
0.876
0.820
0.803
0.792
0.776
0.771
0.731
0.731
0.730
0.702
0.695
0.675
0.672
0.672
0.670
0.665
0.658
0.645
0.628
0.625
0.625
0.616
0.612
0.608
0.607
0.607
0.598
0.597
0.592
0.578
0.571
0.561
0.558
0.535
0.526
0.520

YPL225W
0.515
TAL1
0.508
LEU1
0.506
GPM1
0.503
Enriched proteins in the NLS–GFP–VHL (left) and NES–GFP–VHL (right) interactomes. Normalized median
light/medium (NLS–GFP–VHL) and heavy/medium (NES–GFP–VHL) SILAC ratios from four biologically
independent experiments were log2-transformed. Proteins with log2(SILAC ratio) greater than 0.5
were considered as enriched, yielding 49 and 56 proteins for the NLS and NES interactomes, respectively.

Methods
Yeast media, plasmids and strains
Preparation of yeast media, growth, transformations and manipulations were performed according to standard
protocols. All E3- and chaperone-deletion yeast strains were derived from the BY4742 wild-type strain. Single
deletions were generated by homologous recombination using the NAT gene. The Sis1–DAmP strain was also
generated in this way. Double deletions were generated with both NAT and hygromycin. All strains were
checked by polymerase chain reaction (PCR) using at least two sets of primers.
All ubiquitin K-to-R mutant strains—expressing a single, galactose-inducible ubiquitin gene—were gifts from D.
Finley (Harvard Univ., MA, USA)23. Yeast strains expressing GFP-tagged Doa10 or Hrd1 from their endogenous
loci were from the Yeast-GFP Clone Collection (Thermo Fisher Scientific). The ∆dsk2 strain was obtained from
the Saccharomyces Genome Deletion Project33. We acknowledge gifts of pGAL–CPY‡–GFP (R. Hampton, Univ.
California San Diego, CA, USA), pADH–Flag–Ubr1 and pGAL–San1–V5His6 (D. Wolf, Univ. Stuttgart, Germany),
pFLUC–DM–YFP (F. U. Hartl, Martinsried, Germany), and Ub–M–GFP, Ub–R–GFP, UbG76V–GFP and GFP–CL1 (N.
Dantuma, Karolinska Institute, Stockholm, Sweden)34. All other plasmids were constructed using the Gateway
cloning technology35 as described6.

Galactose shut-off protein expression

Yeast strains transformed with plasmids encoding the galactose-inducible protein of interest were grown
overnight in raffinose synthetic medium at 30 °C before dilution to an optical density at 600 nm (OD600) of
between 0.05 and 0.1 in galactose synthetic medium. The cells were grown for 4–6 h (OD600 0.6–0.8) to induce
expression of the galactose-inducible protein. Expression was shut off by switching the cells to glucose synthetic
medium, and the fate of the existing pool of proteins was assessed according to the appropriate downstream
application.

Counting puncta-containing cells

Cells were grown as described for galactose shut-off protein expression. Following shut-off, cells were allowed
to grow at 30 °C or 37 °C for 1 h in glucose synthetic medium. Note that for WT plus bortezomib conditions,
50 μM bortezomib (LC Laboratories) was dissolved in the glucose synthetic medium before addition. Cells were
then fixed for 15 min in 4% paraformaldehyde before mounting onto concanavalin-A-coated coverslips using
ProLongTM Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific). Fluorescence was visualized using
a Zeiss LSM700 confocal microscope with a ×63 oil-immersion lens. Image analysis was performed by ImageJ
software (http://imagej.nih.gov/ij). 300 cells were counted manually for each blinded sample, and the
percentage of cells containing GFP-positive puncta was noted. Statistical analysis was performed using one-way
ANOVA followed by Dunnett’s multiple comparisons test.

Immunofluorescence

Cells were grown and paraformaldehyde fixed as described above. Fixed cells were spheroplasted by incubating
for 20–40 min at 30 °C with Zymolyase 100T (Zymo Research) in potassium phosphate buffer (0.1 M potassium
phosphate pH 7.5, 1.2 M sorbitol) supplemented with 25 mM DTT and 5 mM EDTA. The resultant spheroplasts
were permeabilized with 0.1% (v/v) Triton X-100 in potassium phosphate buffer for 10 min. For immunostaining,
cells were blocked (potassium phosphate buffer with 1% (w/v) bovine serum albumin (BSA) for 30 min at room
temperature) and incubated overnight at 4 °C with antibodies diluted at the appropriate concentration in
potassium phosphate buffer with 0.1% (w/v) BSA. Antibodies used were against K48–Ub covalently linked to
Alexa Fluor 568 (1/100; Abcam catalogue number ab208136), K11–Ub (1/50; EMD Millipore catalogue number
MABS107-I) covalently linked to Alexa Fluor 647 NHS Ester (Thermo Fisher Scientific), K11/K48–Ub bispecific
antibody (1/500; Genentech) with secondary antibody Cy5-conjugated donkey anti-human (1/1,000; Jackson
ImmunoResearch catalogue number 709-175-149), and Nsp1 (1:500, EnCor catalogue number MCA-32D6) with
secondary antibody Alexa Fluor 568-conjugated goat anti-mouse (1/1,000; Thermo Fisher Scientific catalogue
number A10037) for 1 h at room temperature. Stained cells were mounted onto poly-lysine-coated coverslips
using ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific). Fluorescence was visualized
using a Zeiss LSM700 confocal microscope with × 100, numerical aperture 1.4, oil-immersion lens. Raw data
collected as z-stacks were represented in a single image as maximum-intensity projections (ImageJ).

Cycloheximide chase assay

Cells were grown as described for galactose shut-off protein expression. A first sample with an equivalent
OD600 of 10 (t = 0) was collected before shut-off. The rest of the culture was shifted to glucose synthetic medium
with 50 μg ml−1 cycloheximide, and further cells (OD600 = 10) were collected 10, 30, 60 and 90 min after the shift.
Samples from each time point were pelleted, washed once with 15 mM sodium azide containing 1× Roche
cOmpleteTM EDTA-free protease-inhibitor tablet (Sigma), snap frozen in liquid nitrogen, and stored at −80 °C
until all time points were collected. Proteins were extracted by boiling each sample in an equal volume of
2 × SDS sample buffer (100 mM Tris-HCl pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 200 mM DTT, 0.2% (w/v)
bromophenol blue) for 10 min before detection of protein by SDS–PAGE and immunoblotting.

SDS–PAGE and immunoblotting

Protein samples from cell lysates or immunoprecipitates were denatured in SDS sample buffer (95 °C for 5 min)
or LDS sample buffer (70 °C for 10 min) before separation by SDS–PAGE. Precision Plus prestained protein
standards (Bio-Rad) were used to estimate protein weight. Proteins were transferred onto polyvinylidene
fluoride (PVDF) or nitrocellulose membranes (Bio-Rad) and immunoblotted with primary antibodies against GFP
(1/1,000; Roche catalogue number 11814460001 or Santa Cruz Biotechnology catalogue number sc-9996),
peroxidase anti-peroxidase complex for detection of Protein A in the tandem affinity purification tag (TAP;
1/2,000 to 1/7,500; Sigma catalogue number P1291), glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
1/5,000, Abcam catalogue number ab9485; or 1/10,000, Genetex catalogue number GTX100118), α-tubulin
(1/2,500; DSHB Hybridoma Product 12G10; deposited by J. Frankel and E.M. Nelson), Flag (1/1,000; Cell
Signaling Technology catalogue number 2368), pan-ubiquitin (1/1,000; Life Sensors catalogue number VU101),
K11–Ub (1/100; EMD Millipore catalogue number MABS107-I), K48–Ub (1/1,000; Cell Signaling Technology
catalogue number 12805) or K11/K48–Ub bispecific antibody (1/500; Genentech). Specific primary antibodies
used are indicated next to the uncropped immunoblot images in Supplementary Fig. 1. For immunoblotting of
ubiquitin, samples were separated by SDS–PAGE, transferred to a PVDF membrane and denatured by boiling for
10 min at 95 °C before antibody incubation. Secondary antibodies used were horseradish peroxidase (HRP)conjugated donkey anti-mouse (1/5,000; Jackson ImmunoResearch catalogue number 715-035-150), donkey
anti-rabbit (1/5,000; Jackson ImmunoResearch catalogue number 711-035-152) or donkey anti-human (1/5,000;
Jackson ImmunoResearch catalogue number 709-035-149). The HRP signal was detected by incubation with

Pierce ECL Western blotting substrate (Thermo Fisher Scientific) and exposure to GeneMate Blue Ultra Film
(BioExpress). Immunoblots shown are representative of three independent experiments.

Immunoprecipitation of E3 ligases
To test for co-immunoprecipitation of E3 ligases, we transfected pADH–Flag–Ubr1 or pGAL–San1–V5His6
plasmids into yeast strains from the yeast-GFP collection (expressing GFP-tagged Doa10 or Hrd1 from the
endogenous loci). Each strain was grown overnight in raffinose synthetic media at 30 °C before dilution to an
OD600 of between 0.05 and 0.1 in galactose synthetic media. The cells were grown for 24 h to induce expression
of the galactose-inducible San1–V5His6, diluted back to OD600 = 0.1, and then grown for another 4–6 h
(OD600 0.6–0.8). For consistency between experimental conditions, the same protocol was followed for cells
expressing Flag–Ubr1 from the alcohol dehydrogenase (ADH) promoter, even though this does not require
galactose for expression. Cells were pelleted and washed once with 15 mM sodium azide supplemented with 1×
Roche cOmpleteTM EDTA-free protease-inhibitor tablet (Sigma) and 50 mM 2-chloroacetamide, to inhibit
proteases and deubiquitinases, respectively. Pellets were resuspended in an equal volume of lysis buffer (50 mM
Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM phenylmethane sulfonyl fluoride (PMSF) Roche
cOmpleteTM EDTA-free protease-inhibitor tablet (Sigma), 50 mM 2-chloroacetamide, 10 µM PR-619 (Sigma)) and
frozen drop-wise in liquid nitrogen by passing through a 20.5-gauge syringe. Frozen samples were lysed by
cryogrinding in a Retsch MM-301 (five cycles, 30 Hz, for 3 min per cycle) and proteins solubilized by adding
Triton X-100 (1% v/v final concentration). Lysates were clarified (16,000g for 30 min at 4 °C) and quantified for
total protein by bicinchonic acid (BCA) assay. We incubated 2 mg of lysate with anti-GFP rabbit IgG conjugated
to protein G dynabeads (Thermo Fisher Scientific) for 2 h at 4 °C to immunoprecipitate the GFP-tagged protein
complexes, which were then eluted from the beads by heating for 30 min at 70 °C in non-reducing LDS sample
buffer (Thermo Fisher Scientific). The bead-free samples were reduced with DTT (50 mM final concentration,
10 min at 70 °C) before SDS–PAGE analysis.

Immunoprecipitation of ubiquitinated VHL
For immunoprecipitation of ubiquitinated Flag–VHL, yeast strains were grown as described for galactose shut-off
protein expression. Following shut-off in glucose synthetic medium supplemented with 50 μM Bz for 1 h at
30 °C, cells were pelleted and snap frozen in liquid nitrogen. All subsequent steps were performed at 4 °C or on
ice. Pellets were resuspended in an equal volume of urea lysis buffer (50 mM Tris-HCl pH 7.5, 8 M urea, 150 mM
NaCl, 2 mM EDTA, 1 mM PMSF, Roche cOmpleteTM EDTA-free protease inhibitor tablet (Sigma), 50 mM
chloroacetamide, 10 µM PR-619 (Sigma)) and lysed by bead beating (five cycles at 1 min each, with 1 min on ice
in between cycles). Following dilution tenfold in Triton immunoprecipitation buffer (same composition as urea
lysis buffer, but with 1% v/v Triton X-100 instead of 8 M urea), lysates were clarified (16,000g for 30 min at 4 °C)
and quantified for total protein by BCA assay. We incubated 2 mg of lysates with Flag-M2 magnetic beads
(Sigma) for 2 h at 4 °C to immunoprecipitate the Flag-tagged protein, which was then eluted from the beads by
heating for 30 min at 70 °C in non-reducing LDS sample buffer (Thermo Fisher Scientific), to avoid co-elution of
the Flag antibody. The bead-free samples were reduced with DTT (50 mM final concentration, 10 min at 70 °C)
before SDS–PAGE analysis.
The same protocol was used for denaturing immunoprecipitation of ubiquitinated GFP–VHL, but with addition of
1% w/v SDS in lysis and immunoprecipitation buffers, and incubation with GFP-TRAP_MA magnetic beads
(ChromoTek) instead of Flag-M2 magnetic beads.
For double-immunoprecipitation experiments, 10 mg of cell lysate was incubated with Flag-M2 magnetic beads
for 2 h at 4 °C and eluted from the beads by competition with 3× Flag peptide (Apex Bio). The resultant eluate
was subsequently incubated with an antibody against K48–Ub (1/500; Cell Signaling Technologies catalogue
number 4289) or K11–Ub (1/50; EMD Millipore catalogue number MABS107-I) covalently conjugated using

bis(sulfosuccinimidyl)suberate (BS3) to protein G dynabeads (Thermo Fisher Scientific) overnight at 4 °C. The
bead-bound fraction (‘eluate’) was eluted by heating for 10 min at 70 °C in non-reducing LDS sample buffer, and
analysed alongside the unbound fraction (‘flow-through’) by SDS–PAGE.

Ubiquitin linkage ELISA

For quantification of K11–Ub and K48–Ub linkages on Flag–VHL, cell lysates were prepared as described for
immunoprecipitation of ubiquitinated Flag–VHL. We added 200 μg of lysate protein to each well of an anti-FlagM2-coated 96-well plate and then incubated the plate for 2 h. All incubation steps were performed at room
temperature with gentle shaking. Four wells were used for each technical replicate (two replicates per strain per
experiment). After washing four times with Triton immunoprecipitation buffer to remove unbound protein, each
well was incubated for 1 h with rabbit antibodies against one of GFP (1/1,000; Cell Signaling Technology
catalogue number 2956), Flag (1/1,000; Cell Signaling Technology catalogue number 2368), K11–Ub (1/50; EMD
Millipore catalogue number MABS107-I), or K48–Ub (1/500; Cell Signaling Technology catalogue number 4289)
diluted in 100 μl tris-buffered saline/Tween-20 (TBS-T) buffer with 0.1% BSA. After another four washes, each
well was incubated for 1 h with HRP-conjugated donkey anti-rabbit antibody (1/2,000; Jackson ImmunoResearch
catalogue number 711-035-152) diluted in 100 μl TBS-T with 0.1% BSA, washed another four times with Tween
immunoprecipitation buffer, and incubated for 30 min with 100 μl Pierce tetramethylbenzidine (TMB) substrate
(Thermo Fisher Scientific) followed by 100 μl 0.16 M sulfuric acid to stop the reaction. Absorbance was
measured at 450 nm.
To calculate the K11–Ub or K48–Ub signal for each strain, we subtracted the raw absorbance readings of the
negative control (GFP) signal, and then divided by the Flag signal to account for variations in total Flag–VHL
levels. These K11–Ub or K48–Ub signals were then expressed as a proportion of the K11–Ub or K48–Ub signal in
the WT strain to allow direct comparison between strains. Bars represent means ± s.e.m. from three individual
experiments.
The same protocol was followed for quantification of linkages on GFP-tagged proteins, except with the use of
GFP-multiTrap 96-well plates (ChromoTek) instead of Flag-M2-coated plates, and using the GFP and Flag signals
as positive and negative controls, respectively.

SILAC mass spectrometry of VHL immunoprecipitates

WT yeast cells transfected with one of NLS–GFP–VHL, NES–GFP–VHL or Flag–VHL were grown overnight at 30 °C
in raffinose-synthetic media supplemented with light Lys0 (Cambridge Isotope Laboratories catalogue number
ULM-8766-PK), heavy Lys8 (Cambridge Isotope Laboratories catalogue number CNLM-291-H-1) or medium Lys4
(Cambridge Isotope Laboratories catalogue number DLM-2640-PK), respectively. Cells were diluted to an
OD600 of between 0.05 and 0.1 in galactose synthetic medium supplemented with the appropriate lysine
isotopes and grown for 4–5 h (OD600 0.6–0.8) to induce expression of the galactose-inducible protein. Expression
was shut off by switching the cells to glucose synthetic medium supplemented with the appropriate lysine
isotope. Pelleted cells were lysed by cryogrinding as described in the ‘Immunoprecipitation of E3 ligases’ section
above. Then, 1.5 mg of protein (as quantified by BCA assay) from each of the NLS–GFP–VHL, NES–GFP–VHL and
Flag–VHL lysates were mixed before immunoprecipitation using GFP-TRAP_MA magnetic beads (ChromoTek)
according to the manufacturer’s protocol. After three washes with Triton immunoprecipitation buffer, the beads
were washed twice with 50 mM Tris-HCl pH 8 supplemented with 20 mM CaCl2. On-bead trypsin digestion and
peptide clean-up were performed using the in-StageTip method36. Peptides were analysed on a Q Exactive Plus
Orbitrap (Thermo Fisher Scientific) connected to a NanoAcquity high-performance liquid-chromatography
system (Waters). An EASY-Spray PepMap rapid-separation liquid-chromatography column (C18, 3 µm,
75 µm × 15 cm; Thermo Fisher Scientific) was used to resolve peptides with a binary solvent system (0.1% formic
acid in water as mobile phase A, 0.1% formic acid in acetonitrile as mobile phase B). The Q Exactive Plus was run

on a linear 60-min gradient from 2% to 30% phase B at a flow rate of 300 nl min−1. Both precursor and fragment
ions were analysed in the flow-through (FT) mode at a mass resolution of 70,000 and 17,500, respectively. After
a survey scan, the ten most intense precursor ions were selected for subsequent fragmentation by higherenergy collisional dissociation.
Raw data from four biological replicates were processed using
MaxQuant37 (http://www.coxdocs.org/doku.php?id=maxquant:start, version 1.6.2.3) and searched against
the Saccharomyces Genome Database
(https://downloads.yeastgenome.org/sequence/S288C_reference/orf_protein; downloaded in January 2015)
with common contaminant entries. The default MaxQuant parameters for a triple SILAC experiment were used,
with the exception of ‘Re-quantify’, which was enabled.
The proteinGroups.txt file was filtered to exclude contaminants, reverse hits, hits ‘only identified by site’, and
hits for which only one peptide was identified. The normalized SILAC ratios were used to generate median foldchange values per protein. Proteins with a log2(light/medium) or log2(heavy/medium) value of more than 0.5
were counted as ‘enriched’ in NLS–VHL or NES–VHL interactomes, respectively. Enriched proteins from each
interactome were subjected to pathway analysis to search for enriched Gene Ontology (GO) terms, Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways and PFAM protein domains in either interactome using
the STRING database38 (http://string-db.org, version 10.5).

Reporting summary

Further information on experimental design is available in the Nature Research Reporting Summary linked to
this paper.

Data availability
The data sets generated and/or analysed during this study are available from the corresponding author on
reasonable request. The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the data
identifier PXD010660. Uncropped images of all immunoblots shown in this study are in Supplementary Fig. 1.
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Extended data figures and tables
Extended Data Fig. 1 E3 ligases work in optimal combinations to clear misfolded
proteins.

a, Assay for puncta formation distinguishes between misfolded versus natively folded proteins. WT cells
expressing natively folded Ubc9WT–GFP or temperature-sensitive Ubc9ts–GFP from a galactose-inducible
promoter for 4–6 h at 30 °C were shifted to glucose-containing medium for 1 h at 30 °C or 37 °C to shut off
expression. Cells were fixed and imaged by fluorescence microscopy. 300 cells were counted per condition, and
the percentage of cells with GFP-positive puncta is shown (means ± s.e.m. from three biologically independent
experiments). Only cells expressing Ubc9ts–GFP showed a statistically significant change in the percentage of
puncta-positive cells compared with WT (two-tailed Student’s t-test, ****P < 0.0001; ns, not significant). b,
Deletion of individual E3 ligases does not increase puncta formation. Experiment performed as in panel a, but
using strains with endogenous deletions of the genes shown on the x-axis. E3 ligases that have previously been
implicated in PQC (as shown in Fig. 1d) are grouped to the right (QC, quality control). Bars represent
mean ± s.e.m. from three biologically independent experiments, with the exception of rad5, hel1, etp1, irc20,
hel2, apc11, hrt1, tfb3, cdc24, prp19, upf1, upf3, itt1 and rad18, where bars represent the mean from two

biologically independent experiments, as well as WT, where bars represent the mean ± s.e.m. from seven
biologically independent experiments. No strains showed statistically significant differences compared with WT
by one-way ANOVA followed by Dunnett’s multiple comparisons test. c, Deleting certain pairs of E3 ligases
increases the stability of misfolded proteins. CHX chase was followed by immunoblot to assess the stability of
GFP–VHL, CPY‡–GFP, Ubc9ts–TAP or Ubc9WT–TAP in E3 double-deletion strains. For the WT + Bz condition, 50
μM Bz was added to the glucose-containing medium 10 min before CHX treatment. Graphs represent
densitometric quantification of bands relative to t = 0 (mean ± s.e.m. from three biologically independent
experiments). d, Multiple misfolded proteins are sequestered in the same subcellular location. ∆ubr1∆san1 or
∆doa10∆hrd1 strains co-expressing VHL with temperature-sensitive Ubc9ts (top) or natively folded Ubc9WT
(bottom) from galactose-inducible promoters for 5–6 h at 30 °C were shifted to glucose-containing medium for 1
h at 37 °C. Fluorescence microscopy images are representative of at least 100 cells from each of three
biologically independent experiments. e, Deletion of certain pairs of E3s increases puncta formation. Experiment
performed as in panel a, but in strains with endogenous deletions of pairs of E3 genes. Each right-hand panel
shows experiments in which cells were shifted to 37 °C for the 1 h of galactose shut-off. Bars represent
means ± s.e.m. from three biologically independent experiments. Strains for which statistically significant
differences were observed by one-way ANOVA followed by Dunnett’s multiple comparisons test compared with
WT are indicated with the adjusted P value or with **** for P < 0.0001. f, Overexpressing a single E3 ligase does
not compensate for the loss of others. Ubr1, San1 or Hrd1 were overexpressed alongside GFP–VHL in the
indicated strains. The rest of the experiment was performed as in a. Bars represent means ± s.e.m. from three
biologically independent experiments.

Extended Data Fig. 2 San1 forms a complex with Doa10 but not with Hrd1.

a, b, San1–V5His6 co-immunoprecipitates with Doa10–GFP but not with Hrd1–GFP. Yeast cells co-expressing
Doa10–GFP (a) or Hrd1–GFP (b) from their endogenous promoters with San1–V5His6 from a galactose-inducible
promoter for 16 h were shifted to 37 °C for 1 h, and immediately lysed by cryo-grinding. Native complexes were
immunoprecipitated with GFP-Trap-MA nanobodies before immunoblotting with the indicated antibodies.
Immunoblots are representative of three biologically independent experiments. c, d, Flag–Ubr1 does not coimmunoprecipitate with Doa10–GFP or Hrd1–GFP. The experiment was performed as in panel a and b, but with
cells expressing Flag–Ubr1 (from the constitutive ADH promoter) instead of San1–V5His6. Immunoblots are
representative of three biologically independent experiments.

Extended Data Fig. 3 K48–Ub and K11–Ub linkages are reduced in ∆ubr1∆san1 and
∆doa10∆hrd1 strains, respectively.

a, Diagram showing the Ub-linkage ELISA used to quantify Ub linkages. Flag–VHL from a yeast lysate was
immunoprecipitated in an anti-Flag-conjugated 96-well plate (using four wells per sample), and incubated with
antibodies against GFP (negative control), Flag, K11–Ub, or K48–Ub. Following incubation with a secondary
antibody (anti-rabbit-HRP), the strength of each signal was detected by electrochemiluminescence at 450 nm. To
quantify the K11–Ub or K48–Ub linkages on Flag–VHL, we subtracted the anti-K11 or anti-K48 signal from the
negative control (anti-GFP) and normalized to the total Flag–VHL signal for each sample. b, Ub-linkage ELISA
confirms that K48–Ub and K11–Ub linkages are reduced on Flag–VHL in ∆ubr1∆san1 and ∆doa10∆hrd1 strains,
respectively. WT or E3 double-deletion strains expressing Flag-VHL at 30 °C for 4–6 h were lysed after 1 h Bz
treatment, also at 30 °C. Ub-linkage ELISA was then performed as described in a. Bars represent Flag-normalized
values from each strain (mean ± s.e.m. from three biologically independent experiments), expressed as a
proportion of the Flag-normalized WT values. Strains with statistically significant differences compared with WT
by one-way ANOVA followed by Dunnett’s multiple comparisons test are indicated (****P < 0.001). c, GFP–VHL
denaturing immunoprecipitation (1% SDS + 8 M urea) followed by immunoblot for K48–Ub or K11–Ub in WT or
E3 double-deletion strains. Immunoblots are representative of three independent experiments. d, Relative
amounts of K11–Ub and K48–Ub linkages present on GFP–VHL in ∆ubr1∆san1 or ∆doa10∆hrd1 strains compared
with WT. WT or E3 double-deletion strains expressing GFP–VHL at 30 °C for 5–6 h were lysed in denaturing
conditions (1% SDS + 8 M urea) after 1 h Bz treatment, also at 30 °C. Ub-linkage ELISA was then performed using
GFP-multiTrap plates. Bars represent GFP-normalized values from each strain (means ± s.e.m. from three
biologically independent experiments) expressed as a proportion of the GFP-normalized WT values. Strains for
which statistically significant differences were observed by one-way ANOVA followed by Dunnett’s multiple
comparisons test compared with WT are indicated with the adjusted P value, or with **** for P < 0.0001.

Extended Data Fig. 4 K11–Ub linkages are not necessary for proteasomal degradation of
all cytoplasmic substrates.

a–d, WT or UbK11R cells expressing stable Ub-M-GFP (a), the N-end-rule substrate Ub-R-GFP (b), the ubiquitin
fusion degradation (UFD) substrate UbG76V–GFP (c) or GFP fused to the artificial degron CL1 (d) from galactoseinducible promoters for 4–6 h at 30 °C were shifted to glucose-containing medium for 1 h at 30 °C or 37 °C to
shut off expression. Cells were fixed and imaged by fluorescence microscopy. 300 cells were counted per
condition, and the percentage of cells with GFP-positive puncta is shown (mean ± s.e.m. from three biologically
independent experiments). There was a statistically significant increase in puncta compared with WT when GFPCL1 (which contains a short amphipathic CL1 helix that could mimic a partially unfolded protein) was expressed
in UbK11R cells, as judged by two-tailed Student’s t-test (P = 0.0127). The differences for all other substrates
were not significant (ns, P > 0.05). DUB, deubiquitinating enzyme, which cleaves Ub from Ub-M-GFP or Ub-RGFP.

Extended Data Fig. 5 Misfolded VHL is modified with branched K11/K48 ubiquitin chains.

a, b, Both K11–Ub and K48–Ub linkages are present on the same VHL molecule. a, This experiment was designed
to determine whether both K48–Ub and K11–Ub linkages are present in the same VHL population. Sequential
immunoprecipitation was carried out, first with anti-Flag antibody, then with an anti-K11–Ub or anti-K48–Ub
antibody. The resulting negative control (‘no Flag’, with mock Flag plus K11 or K48 immunoprecipitation with
lysate from cells expressing GFP–VHL instead of Flag–VHL), bead control (‘Control’, with no K11–Ub or K48–Ub
antibody), ‘Bound’ and ‘Flow-through’, in addition to samples with just the first Flag immunoprecipitation
(Input), were subjected to SDS–PAGE and immunoblotted for the presence of the other Ub linkage
(b).Immunoblots representative of three biologically independent experiments are shown. The arrow indicates
the size of un-ubiquitinated Flag–VHL. The asterisks indicate proteins in the stacking gel that did not enter the
resolving gel. c, This bispecific anti-K11/K48–Ub antibody was designed to bind ubiquitin chains with K11 and
K48 linkages branching off the same ubiquitin moiety. d, Misfolded VHL co-localizes with K11/K48–Ub chains.
WT cells expressing GFP–VHL from a galactose-inducible promoter for 4–6 h at 30 °C were shifted to glucosecontaining medium with 50 μM bortezomib for 1 h to shut off expression. Cells were fixed, spheroplasted and
detergent permeabilized before immunostaining with an antibody designed to recognize ubiquitin that had K11
and K48 linkages emanating from the same moiety (K11/K48). Confocal fluorescence microscopy images are
representative of at least 100 cells from each of three biologically independent experiments. Scale bars
represent 2 μm. e, VHL is modified with branched K11/K48–Ub chains. GFP–VHL denaturing
immunoprecipitation was followed by immunoblot for K11/K48–Ub or GFP (VHL) in WT or E3 double-deletion
strains. Immunoblots representative of three biologically independent experiments are shown.

Extended Data Fig. 6 Nuclear and cytoplasmic proteins require different PQC pathways
for clearance.

a, NLS–GFP–VHL and NES–GFP–VHL form a single punctum in the nucleus or cytoplasm, respectively, upon
proteasome inhibition. WT cells expressing NLS–GFP–VHL or NES–GFP–VHL from a galactose-inducible promoter
for 4–6 h at 30 °C were shifted to glucose-containing medium with 50 μM Bz for 1 h at 30 °C to shut off GFP–VHL
expression. Fixed and spheroplasted cells were immunostained for the nuclear pore complex protein Nsp1 (red)
before imaging by fluorescence microscopy. Representative cells from three biologically independent repeats
are shown. b–d, Misfolded luciferasets (Lucts) confined to the nucleus can be cleared by San1-mediated K48linked ubiquitination. b, The increase in the percentage of cells containing puncta of NLS–GFP–Lucts and NES–
GFP–Lucts across the E3 single- and double-deletion strains is similar to the pattern observed with NLS–GFP–VHL
and NES–GFP–VHL in Fig. 4. Shown is the percentage of cells (mean ± s.e.m. from three biologically independent
experiments, each with n = 300) containing NLS–GFP–Lucts or NES–GFP–Lucts puncta in WT, single- or doubledeletion strains after 4–6 h expression of the protein at 30 °C followed by 1 h shut-off at 37 °C. Strains for which
statistically significant differences were observed by one-way ANOVA followed by Dunnett’s multiple
comparisons test compared with WT are indicated with the adjusted P value, or with **** for P < 0.0001. c,
Misfolded nuclear Lucts has severely reduced K11–Ub linkages (****P < 0.0001 by one-way ANOVA followed by
Dunnett’s multiple comparisons test). Ubiquitin-linkage ELISA was performed on lysates of WT yeast expressing
NLS-, NES- or unaltered GFP–Lucts at 37 °C as described in Extended Data Fig. 2c, but in GFP-multiTrap 96-well
plates instead of anti-Flag-conjugated 96-well plates. Anti-Flag was used instead of anti-GFP as the ELISA
negative control. Bars represent means ± s.e.m. from three biologically independent experiments. d, Misfolded
luciferasets confined to the nucleus does not require K11–Ub linkages for clearance. The experiment was
performed as in panel b, but with yeast strains expressing WT or mutant K11R–Ub as their sole source of
ubiquitin. 300 cells were counted per condition, and the percentages of cells with GFP-positive puncta are
shown in (means ± s.e.m. from three biologically independent experiments). Only NES–GFP–Lucts had a
statistically significant change in puncta-positive cells in the K11R strain when compared with WT (one-way
ANOVA followed by Dunnett’s multiple comparisons test; ****P < 0.0001; ns = P > 0.05). e, VHL confined to the
nucleus (NLS) or cytoplasm (NES) requires different chaperones for clearance. The experiment was performed as

in panel b, but with the indicated chaperone-deletion strains. Bars represent means ± s.e.m. from three
biologically independent experiments. Strains for which statistically significant differences were observed
compared with WT by one-way ANOVA followed by Dunnett’s multiple comparisons test are indicated with the
adjusted P value, or with **** for P < 0.0001.

Extended Data Fig. 7 Mass spectrometry of the VHL interactome identifies distinct PQC
circuitries for nuclear and cytoplasmic VHL.

a, Triple SILAC-base mass spectrometry of VHL immunoprecipitates. WT yeast cells transfected with one of NLS–
GFP–VHL, NES–GFP–VHL or Flag–VHL were grown overnight at 30 °C in raffinose-synthetic media supplemented
with light Lys0, heavy Lys8 or medium Lys4, respectively. Growth of VHL was induced in galactose for 4–5 h
before shut off in glucose for 90 min. Next, 1.5 mg of protein from each of the three lysed samples were mixed
before immunoprecipitation using GFP-TRAP_MA magnetic bead on-bead restriction digestion and peptide
clean-up. Peptides were identified using liquid-chromatography/mass-spectrometry analysis before analysis
using MaxQuant. b, Strong correlation between the four biological repeats (R1–R4). Raw intensities for light
(NLS–GFP–VHL; top), heavy (NES–GFP–VHL; middle) and medium (VHL–Flag control, bottom) were log10transformed and plotted as scatterplot matrices. The Pearson correlation coefficient for each pairwise
comparison is indicated, and the density distribution of intensities within each repeat is shown in the diagonal
axis of the matrices. c, Enriched PQC proteins in NLS–GFP–VHL and NES–GFP–VHL interactomes. Normalized
median light/medium (NLS–GFP–VHL) and heavy/medium (NES–GFP–VHL) SILAC ratios were log2-transformed.
Proteins with log2(SILAC ratio) of greater than 0.5 were considered as enriched, yielding 49 and 56 proteins for
the NLS and NES interactomes, respectively. Enriched proteins known to play a role in PQC are shown. Both
nuclear and cytoplasmic VHL share enrichments in proteasomal subunits, the Hsp70 chaperones Ssa1, Ssa2, Ssa4
and Ssb2, and the thioredoxins Trx1, Trx2 and Tsa1 (previously implicated in misfolded-protein management).
All enriched proteins are shown in Extended Data Table 1. d, Enriched PQC pathways in NLS–GFP–VHL and NES–
GFP–VHL interactomes. The enriched proteins from each interactome (median values from four biologically
independent experiments) were subjected to pathway analysis to search for enriched GO terms, KEGG pathways
and PFAM protein domains in either interactome using the STRING database. Selected enriched PQC pathways
are shown (P < 0.05 using Fisher’s exact test followed by Benjamini–Hochberg multiple testing correction).

Extended data table 2 | human homologues of the ubiquitination machinery
characterized here are associated with a range of diseases
Yeast
gene
Doa10

Human orthologue

Associated Diseases

MARCH6/TEB4

Hrd1

HRD1

UBR1

Cri-du-chat syndrome (same chromosomal
region)39 ;
Lipidogenesis imbalance 40-42
Alzheimer 's Disease
Parkinson's Disease
Cancer
Cystic fibrosis
ALS
Parkinson's Disease
Huntington's Disease
Prion disorders
Johanson-Blizzard Syndrome45

UBR4

Episod ic Ataxia Type 8 46

UBR5

Adult Myoclonal Epilepsy

UBR7

Autism Spectrum Disorder 46

No clear human
orthologue
UBQLN1

-

-

Alzheimer's Disease
Huntington's Disease

51,58

Gp78/AMFR

Ubr1

San1
Dsk2

PQC in disease
pathology?
43

(Review)

44

(Review)

45

Unclear (yes for related
Types 1
& 2) 47,48
46
Unclear (yes for related
Lafora
Myoclonal Epilepsy) 49
50-56

(Reviews), 59,60

UBQLN2

61-65
ALS
Frontotemporal Dementia
Huntington's Disease
Literature-based evidence for disease pathology being directly related to PQC is indicated in the last column,
where applicable. References cited are39-65.

